 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
Protein kinases
|
|
Cytokines and receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
 Enzymes
|
Oxidoreductases (EC1)
|
Dehydrogenases [EC:1.1.1.-]
|
Oxidases [EC:1.1.3.-]
|
Dehydrogenases [EC:1.2.1.-]
|
Dehydrogenases [EC:1.3.-.-]
|
Amine oxidases [EC:1.4.3.-]
|
DAO [HSA:1610] [KO:K00273]
|
MAO [HSA:4128 4129] [KO:K00274]
|
 D05458 Phentermine (USAN/INN)
D05459 Phentermine hydrochloride (USP) <US>
D08453 Pargyline (INN)
D02564 Pargyline hydrochloride (USAN)
D02580 Isocarboxazid (INN) <US>
D07337 Nialamide (INN)
D08349 Phenelzine (BAN)
D00505 Phenelzine sulfate (USP) <US>
D08625 Tranylcypromine (INN)
D00826 Tranylcypromine sulfate (USP) <US>
D02579 Iproniazid (INN)
D08085 Iproniazid phosphate
D07338 Iproclozide (INN)
D01888 Safrazine hydrochloride (JAN)
D03239 Ladostigil tartrate (USAN)
D03409 Caroxazone (USAN/INN)
D04092 Etryptamine acetate (USAN)
|
MAOA [HSA:4128] [KO:K00274]
|
MAOB [HSA:4129] [KO:K00274]
|
AOC3 [HSA:8639] [KO:K00276]
|
AOC1 (DAO) [HSA:26] [KO:K11182]
|
Dihydrofolate reductase [EC:1.5.1.3]
|
NAD(P)H dehydrogenase [EC:1.6.5.2]
|
Peroxidase [EC:1.11.1.-]
|
Peroxygenase [EC:1.11.2.-]
|
Dioxygenases [EC:1.13.11.-]
|
Prolyl 4-hydroxylase [EC:1.14.11.2]
|
HIF hydroxylase [EC:1.14.11.29]
|
Nitic oxide synthase [EC:1.14.13.39]
|
Cytochrome P450 [EC:1.14.14.-]
|
Other monooxygenases [EC:1.14.16.- 1.14.17.- 1.14.18.-]
|
Prostaglandin synthase [EC:1.14.99.1]
|
Histone demethylase [EC:1.14.99.66]
|
Superoxide dismutase [EC:1.15.1.1]
|
Xanthine dehydrogenase/oxidase [EC:1.17.1.4 1.17.3.2]
|
Ribonucleoside-diphosphate reductase [EC:1.17.4.1]
|
Vitamin-K-epoxide reductase [EC:1.17.4.4]
|
Thyroxine 5'-deiodinase [EC:1.21.99.4]
|
Transferases (EC2)
|
Hydrolases (EC3)
|
Lyases (EC4)
|
Isomerases (EC5)
|
Ligases (EC6)
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Target-based Classification of Drugs